Clinical trial
Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer
NCT02102438
Study timeline
Study start (unknown)2014-04-01Date precision: month
Registry last updated2016-08-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
HER-2 Positive Breast Cancerunresolved
Interventions
TrastuzumabDRUG · verified · RxNorm: trastuzumab
CarboplatinDRUG · verified · RxNorm: carboplatin
Sponsors & collaborators
Instituto do Cancer do Estado de São Paulolead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02102438 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.